AB SCIEX and Phenomenex to Drive Food Safety Testing Discussions at Frito-Lay North America Venue in Dallas on March 30

DALLAS-- Food safety testing is now on wheels, and it’s coming to Dallas as part of a progressive North American tour to raise awareness about improving food safety. A state-of-the-art mobile laboratory that is run by AB SCIEX and Phenomenex, two scientific technology leaders, will be open for visitors at the Frito-Lay North America site [...]

Block MEMS Wins Contract to Participate in the Multi-Mission Multi-Threat Detection (M3TD) Program

Block MEMS has been awarded a contract by the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) to provide its LaserScan™ Analyzer for evaluation in the Multi-Mission Multi-Threat Detection (M3TD) Technology Evaluation program. The goal of the M3TD program is to evaluate currently available technology for chemical detection and the [...]

PerkinElmer Highlights Innovative Solutions for Enabling Personalized Medicine in Cancer Research at AACR 2012

WALTHAM, Mass.– At the American Association for Cancer Research 2012 Annual Meeting (Booth #2306), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will be showcasing numerous solutions, posters and knowledge-sharing events in support of cancer-focused personalized medicine research. "PerkinElmer remains committed to [...]

Perten Headquarters Relocates to Larger Building

Perten Instruments headquarters in Stockholm, Sweden has moved to larger offices. Göran Sandén – Head of Global After-Market – states “We’ve added 11 new service, applications specialists, and engineers in the last two years. We were bursting at the seams in our old building. The new offices allow us to continue our growth in after-sales [...]

Asuragen awarded $6.8 million commercialization award from the Cancer Prevention and Research Institute of Texas

Austin, Texas – Asuragen, Inc. announced today that the Company received notice of a $6.8 million commercialization award to pursue Next Generation Sequencing (NGS) applications from the State of Texas through the Cancer Prevention and Research Institute of Texas (“CPRIT”). CPRIT was established to expedite innovation and commercialization in the area of cancer research and [...]

Transgenomic, Inc. Announces Presentation of Results from 448-Gene NuclearMitome Test in 78 Patients at the 2012 Annual Meeting of the American College of Medical Genetics

OMAHA, Neb.,– Transgenomic, Inc. today announced that Jeana DaRe, Ph.D., Assistant CLIA Laboratory Director at Transgenomic, presented clinical findings from patients tested for nuclear mitochondrial disorders using Transgenomic’s NuclearMitome Test on Thursday, March 29, at the 2012 Annual Meeting of the American College of Medical Genetics (ACMG) in Charlotte, North Carolina. The discussion, titled “Clinical [...]

GENALYTE, INC. COMPLETES $12 MILLION SERIES B FINANCING TO COMMERCIALIZE ITS MAVERICKTM NEXT-GENERATION MULTIPLEXING PLATFORM

SAN DIEGO, CA — Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced completion of an $11.8 million Series B financing. New investors Redmile Group and Claremont Creek Ventures and private investors from Genalyte’s Series A round participated in the Series B financing. Genalyte intends to use the new [...]

Abbott’s PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking

Wiesbaden, Germany — Abbott announced today it has obtained CE Marking (Conformité Européene) in the European Union to market its rapid, high-throughput PLEX-ID™ instrument, along with three assays for use on the system: PLEX-ID Viral IC Spectrum, PLEX-ID BAC Spectrum BC and PLEX-ID Flu. PLEX-ID, which is based on molecular diagnostic technologies, addresses a significant [...]

Roche Receives FDA Approval for cobas p 630 Pre-analytical Solution for Automated Molecular Testing Platform

PLEASANTON, Calif.,- Roche announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molecular testing platform. The cobas p 630 Instrument, being introduced with new AMPLILINK 3.3 series software, unites primary tube handling with fully automated sample preparation, amplification and detection for [...]

FDA Detectives use Stomacher® 400 circulator for sample preparation in cantaloupe Listeriosis scare

Worthing, UK – Seward, the manufacturer and developer of the patented Stomacher® Paddle Blender range, highlights the use of the Stomacher® 400 Circulator in the elimination of soil and fruit as possible sources in a recent fatal cantaloupe melon Listeriosis scare. At the height of the scare the outbreak detectives of the FDA were mystified [...]

Access IBO on Knowledge Center